Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Oxidation and amidation of salicylate by Streptomyces species.

Pospíšil S, Přikrylová V, Němeček J, Spížek J.

Can J Microbiol. 1996 Aug;42(8):867-9. doi: 10.1139/m96-111.

PMID:
22050000
2.
3.

Identification of odorous compounds from nine fermentor-cultivated Streptomyces strains.

Rezanka T, Prell A, Sigler K.

Folia Microbiol (Praha). 2008;53(4):315-8. doi: 10.1007/s12223-008-0049-3. Epub 2008 Aug 31.

PMID:
18759115
4.

Desferrioxamine E produced by Streptomyces griseus stimulates growth and development of Streptomyces tanashiensis.

Yamanaka K, Oikawa H, Ogawa HO, Hosono K, Shinmachi F, Takano H, Sakuda S, Beppu T, Ueda K.

Microbiology. 2005 Sep;151(Pt 9):2899-905.

PMID:
16151202
5.

Overexpression and biochemical characterization of DagA from Streptomyces coelicolor A3(2): an endo-type β-agarase producing neoagarotetraose and neoagarohexaose.

Temuujin U, Chi WJ, Lee SY, Chang YK, Hong SK.

Appl Microbiol Biotechnol. 2011 Nov;92(4):749-59. doi: 10.1007/s00253-011-3347-7. Epub 2011 Jun 8.

PMID:
21655986
6.

Novel metabolites of warfarin produced by Beauveria bassiana and Streptomyces rimosus: a novel application of hplc-nmr.

Cannell RJ, Rashid T, Ismail IM, Sidebottom PJ, Knaggs AR, Marshall PS.

Xenobiotica. 1997 Feb;27(2):147-57.

PMID:
9058529
7.

Production of a novel dimeric metabolite of primaquine by Streptomyces rimosus.

Clark AM, Hufford CD, Puri RK, McChesney JD.

Appl Environ Microbiol. 1984 Mar;47(3):540-3.

8.

Identification of Streptomyces odor spectrum.

Jáchymová J, Votruba J, Víden I, Rezanka T.

Folia Microbiol (Praha). 2002;47(1):37-41. Erratum in: Folia Microbiol (Praha). 2002;47(2):200..

PMID:
11980268
9.

Plasma and synovial fluid gentisate in patients receiving salicylate therapy.

Cleland LG, Lowthian PJ, Imhoff D, Bochner F, Betts WH, O'Callaghan J.

J Rheumatol. 1985 Feb;12(1):136-9.

PMID:
3981499
10.

Lapstatin, a new aminopeptidase inhibitor produced by Streptomyces rimosus, inhibits autogenous aminopeptidases.

Repic Lampret B, Kidric J, Kralj B, Vitale L, Pokorny M, Renko M.

Arch Microbiol. 1999 May-Jun;171(6):397-404.

PMID:
10369895
12.
13.

Microbial biotransformation of the angiotensin II antagonist GR117289 by Streptomyces rimosus to identify a mammalian metabolite.

Cannell RJ, Knaggs AR, Dawson MJ, Manchee GR, Eddershaw PJ, Waterhouse I, Sutherland DR, Bowers GD, Sidebottom PJ.

Drug Metab Dispos. 1995 Jul;23(7):724-9.

PMID:
7587961
14.
16.

Comparative analysis of eukaryotic-type protein phosphatases in two streptomycete genomes.

Shi L, Zhang W.

Microbiology. 2004 Jul;150(Pt 7):2247-56.

PMID:
15256567
17.
19.

Regioselective hydroxylation of isoflavones by Streptomyces avermitilis MA-4680.

Roh C, Seo SH, Choi KY, Cha M, Pandey BP, Kim JH, Park JS, Kim DH, Chang IS, Kim BG.

J Biosci Bioeng. 2009 Jul;108(1):41-6. doi: 10.1016/j.jbiosc.2009.02.021.

PMID:
19577190
20.

Supplemental Content

Support Center